
Browse
	Faculties & Departments
	Issue Date
	Author
	Title
	Communities & Collections

Sign on to:
	My DSpace authorized users

Search Results

Search:

for

Results 1-50 of 173.

Sort items by In order | Results/Page Authors/record

Item hits:

Issue Date	Title	Author(s)
2013	Preleukemie: een 'bejaarde' ziekte?	Witte, T.J. de
2012	Reply to "Infliximab therapy in hematologic malignancies: handle with care" 2012;97(8):e26.	Baron, F.; Witte, T.J. de
2012	Possible high risk of thrombotic events in patients with paroxysmal nocturnal haemoglobinuria after discontinuation of eculizumab.	Bijnen, S.T.A. van; Rijn, R.S. van; Koljenovic, S.; Boekhorst, P. Te; Witte, T.J. de; Muus, P.
2012	EORTC Leukemia Group Achievements	Willemze, R.; Suciu, S.; Marie, J.P.; Karrasch, M.; Jansen, J.H.; Amadori, S.; Muus, P.; Labar, B.; Baron, F.; Selleslag, D.; Wijermans, P.; Bron, D.; Hagemeijer, A.; Meloni, G.; Lubbert, M.; Witte, T.J. de
2012	Human mitochondrial ATP-binding cassette transporter ABCB10 is required for efficient red blood cell development	Tang, L.; Bergevoet, S.M.; Bakker-Verweij, G.; Harteveld, C.L.; Giordano, P.C.; Nijtmans, L.; Witte, T.J. de; Jansen, J.H.; Raymakers, R.A.; van der Reijden, B.A.
2012	Prophylaxis and treatment of GVHD after allogeneic haematopoietic SCT: a survey of centre strategies by the European Group for Blood and Marrow Transplantation.	Ruutu, T.; Biezen, A. van; Hertenstein, B.; Henseler, A.; Garderet, L.; Passweg, J.; Mohty, M.; Sureda, A.; Niederwieser, D.; Gratwohl, A.; Witte, T.J. de
2012	Value of infliximab (Remicade(R)) in patients with low-risk myelodysplastic syndrome: final results of a randomized phase II trial (EORTC trial 06023) of the EORTC Leukemia Group.	Baron, F.; Suciu, S.; Amadori, S.; Muus, P.; Zwierzina, H.; Denzlinger, C.; Delforge, M.; Thyss, A.; Selleslag, D.; Indrak, K.; Ossenkoppele, G.; Witte, T.J. de
2012	Hematopoietic stem cell transplantation in T-prolymphocytic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation and the Royal Marsden Consortium.	Wiktor-Jedrzejczak, W.; Dearden, C.; Wreede, L. de; Biezen, A. van; Brinch, L.; Leblond, V.; Brune, M.; Volin, L.; Kazmi, M.; Nagler, A.; Schetelig, J.; Witte, T.J. de; Dreger, P.
2012	Competing risks in epidemiology: possibilities and pitfalls.	Andersen, P.K.; Geskus, R.B.; Witte, T.J. de; Putter, H.
2012	The EBMT activity survey: 1990-2010.	Passweg, J.R.; Baldomero, H.; Gratwohl, A.; Bregni, M.; Cesaro, S.; Dreger, P.; Witte, T.J. de; Farge-Bancel, D.; Gaspar, B.; Marsh, J.; Mohty, M.; Peters, C.; Tichelli, A.; Velardi, A.; Elvira, C.R. de; Falkenburg, F.; Sureda, A.; Madrigal, A.
2012	Current status of hematopoietic cell transplantation in the treatment of systemic amyloid light-chain amyloidosis.	Schonland, S.O.; Dreger, P.; Witte, T.J.M. de; Hegenbart, U.
2012	Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group.	Westers, T.M.; Ireland, R.; Kern, W.; Alhan, C.; Balleisen, J.S.; Bettelheim, P.; Burbury, K.; Cullen, M.; Cutler, J.A.; Porta, M.G. Della; Drager, A.M.; Feuillard, J.; Font, P.; Germing, U.; Haase, D.; Johansson, U.; Kordasti, S.; Loken, M.R.; Malcovati, L.; Marvelde, J.G. Te; Matarraz, S.; Milne, T.; Moshaver, B.; Mufti, G.J.; Ogata, K.; Orfao, A.; Porwit, A.; Psarra, K.; Richards, S.J.; Subira, D.; Tindell, V.; Vallespi, T.; Valent, P.; Velden, V.H. van der; Witte, T.J.M. de; Wells, D.A.; Zettl, F.; Bene, M.C.; Loosdrecht, A.A. van de
2012	Intensive consolidation therapy compared with standard consolidation and maintenance therapy for adults with acute myeloid leukaemia aged between 46 and 60 years: final results of the randomized phase III study (AML 8B) of the European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups.	Hengeveld, M.; Suciu, S.; Karrasch, M.; Specchia, G.; Marie, J.P.; Muus, P.; Petti, M.C.; Rotoli, B.; Amadori, S.; Fioritoni, G.; Leoni, P.; Morra, E.; Thaler, J.; Resegotti, L.; Fazi, P.; Vignetti, M.; Mandelli, F.; Zittoun, R.; Witte, T.J. de
2012	Autologous and allogeneic stem-cell transplantation for transformed chronic lymphocytic leukemia (Richter's syndrome): A retrospective analysis from the chronic lymphocytic leukemia subcommittee of the chronic leukemia working party and lymphoma working party of the European Group for Blood and Marrow Transplantation.	Cwynarski, K.; Biezen, A. van; Wreede, L. de; Stilgenbauer, S.; Bunjes, D.; Metzner, B.; Koza, V.; Mohty, M.; Remes, K.; Russell, N.; Nagler, A.; Scholten, M.; Witte, T.J. de; Sureda, A.; Dreger, P.
2012	Superiority of the Triple Combination of Bortezomib-Thalidomide-Dexamethasone Over the Dual Combination of Thalidomide-Dexamethasone in Patients With Multiple Myeloma Progressing or Relapsing After Autologous Transplantation: The MMVAR/IFM 2005-04 Randomized Phase III Trial From the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.	Garderet, L.; Iacobelli, S.; Moreau, P.; Dib, M.; Lafon, I.; Niederwieser, D.; Masszi, T.; Fontan, J.; Michallet, M.; Gratwohl, A.; Milone, G.; Doyen, C.; Pegourie, B.; Hajek, R.; Casassus, P.; Kolb, B.; Chaleteix, C.; Hertenstein, B.; Onida, F.; Ludwig, H.; Ketterer, N.; Koenecke, C.; Os, M. van; Mohty, M.; Cakana, A.; Gorin, N.C.; Witte, T.J. de; Harousseau, J.L.; Morris, C.; Gahrton, G.
2011	Cardiopulmonary bypass in a patient with classic paroxysmal nocturnal hemoglobinuria during treatment with eculizumab	Bijnen, S.T.A. van; Vermeer, H.; Mourisse, J.M.J.; Witte, T.J.M. de; Swieten, H.A. van; Muus, P.
2011	Analysis of the REL polymorphism rs13031237 in autoimmune diseases	Varade, J.; Palomino-Morales, R.; Ortego-Centeno, N.; Diaz-Rubio, M.; Fernandez-Gutierrez, B.; Gonzalez-Gay, M.A.; Pascual-Salcedo, D.; Balsa, A.; Iglesias, A.; Gomez-Garcia, M.; Witte, T.J.M. de; Radstake, T.R.D.J.; Coenen, M.J.H.; Urcelay, E.; Martin, J.
2011	Allogeneic stem cell transplantation for myelodysplastic syndromes: critical for cure?	Witte, T.J.M. de
2011	Corrigendum: Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus.	Radstake, T.R.D.J.; Gorlova, O.; Rueda, B.; Martin, J.E.; Alizadeh, B.Z.; Palomino-Morales, R.; Coenen, M.J.H.; Vonk, M.C.; Voskuyl, A.E.; Schuerwegh, A.J.; Broen, J.C.; Riel, P.L.C.M. van; Slot, R. van 't; Italiaander, A.; Ophoff, R.A.; Riemekasten, G.; Hunzelmann, N.; Simeon, C.P.; Ortego-Centeno, N.; Gonzalez-Gay, M.A.; Gonzalez-Escribano, M.F.; Airo, P.; Laar, J. van; Herrick, A.; Worthington, J.; Hesselstrand, R.; Smith, V.; Keyser, F. de; Houssiau, F.; Chee, M.M.; Madhok, R.; Shiels, P.; Westhovens, R.; Kreuter, A.; Kiener, H.; Baere, E. de; Witte, T.J.M. de; Padykov, L.; Klareskog, L.; Beretta, L.; Scorza, R.; Lie, B.A.; Hoffmann-Vold, A.M.; Carreira, P.; Varga, J.; Hinchcliff, M.; Gregersen, P.K.; Lee, A.T.; Ying, J.; Han, Y.; Weng, S.F.; Amos, C.I.; Wigley, F.M.; Hummers, L.; Nelson, J.L.; Agarwal, S.K.; Assassi, S.; Gourh, P.; Tan, F.K.; Koeleman, B.P.; Arnett, F.C.; Martin, J.; Mayes, M.D.
2011	The European LeukemiaNet: achievements and perspectives	Hehlmann, R.; Grimwade, D.; Simonsson, B.; Apperley, J.; Baccarani, M.; Barbui, T.; Barosi, G.; Bassan, R.; Bene, M.C.; Berger, U.; Buchner, T.; Burnett, A.; Cross, N.C.; Witte, T.J. de.; Dohner, H.; Dombret, H.; Einsele, H.; Engelich, G.; Foa, R.; Fonatsch, C.; Gokbuget, N.; Gluckman, E.; Gratwohl, A.; Guilhot, F.; Haferlach, C.; Haferlach, T.; Hallek, M.; Hasford, J.; Hochhaus, A.; Hoelzer, D.; Kiladjian, J.J.; Labar, B.; Ljungman, P.; Mansmann, U.; Niederwieser, D.; Ossenkoppele, G.; Ribera, J.M.; Rieder, H.; Serve, H.; Schrotz-King, P.; Sanz, M.A.; Saussele, S.
2011	Association of a non-synonymous functional variant of the ITGAM gene with systemic sclerosis	Carmona, F.D.; Simeon, C.P.; Beretta, L.; Carreira, P.; Vonk, M.C.; Rios-Fernandez, R.; Espinosa, G.; Navarrete, N.; Vicente-Rabaneda, E.; Rodriguez-Rodriguez, L.; Tolosa, C.; Garcia-Hernandez, F.J.; Castellvi, I.; Egurbide, M.V.; Fonollosa, V.; Gonzalez-Gay, M.A.; Rodriguez-Carballeira, M.; Diaz-Gonzalez, F.; Saez-Comet, L.; Hesselstrand, R.; Riemekasten, G.; Witte, T.J.M. de; Voskuyl, A.E.; Schuerwegh, A.J.; Madhok, R.; Shiels, P.; Fonseca, C.; Denton, C.; Nordin, A.; Palm, O.; Hoffmann-Vold, A.M.; Airo, P.; Scorza, R.; Lunardi, C.; Laar, J.M. van; Hunzelmann, N.; Kreuter, A.; Herrick, A.; Worthington, J.; Koeleman, B.P.; Radstake, T.R.D.J.; Martin, J.
2011	The functional polymorphism 844 A>G in FcalphaRI (CD89) does not contribute to systemic sclerosis or rheumatoid arthritis susceptibility	Broen, J.C.; Coenen, M.J.H.; Rueda, B.; Witte, T.J.M. de; Padyukov, L.; Klareskog, L.; Hesselstrand, R.; Wuttge, D.M.; Simeon, C.; Ortego-Centeno, N.; Gonzalez-Gay, M.A.; Pros, A.; Hunzelman, N.; Riemekasten, G.; Kreuter, A.; Vonk, M.C.; Scorza, R.; Beretta, L.; Airo, P.; Riel, P.L. van; Kimberly, R.; Martin, J.; Edberg, J.; Radstake, T.R.D.J.
2011	PD-1/PD-L1 interactions contribute to functional T-cell impairment in patients who relapse with cancer after allogeneic stem cell transplantation	Norde, W.J.; Maas, F.; Hobo, W.A.; Korman, A.; Quigley, M.; Kester, M.G.; Hebeda, K.M.; Falkenburg, J.H.F.; Schaap, N.P.M.; Witte, T.J.M. de; Voort, R. van der; Dolstra, H.
2011	Clinical-grade generation of active NK cells from cord blood hematopoietic progenitor cells for immunotherapy using a closed-system culture process	Spanholtz, J.; Preijers, F.W.M.B.; Tordoir, M.; Trilsbeek, C.; Paardekooper, J.; Witte, T.J.M. de; Schaap, N.P.M.; Dolstra, H.
2011	Unrelated cord blood transplantation in adults with myelodysplasia or secondary acute myeloblastic leukemia: a survey on behalf of Eurocord and CLWP of EBMT	Robin, M.; Sanz, G.F.; Ionescu, I.; Rio, B.; Sirvent, A.; Renaud, M.; Carreras, E.; Milpied, N.; Mohty, M.; Beguin, Y.; Bordigoni, P.; Witte, T.J.M. de; Picardi, A.; Purtill, D.; Gluckman, E.; Kroger, N.; Rocha, V.
2011	Autologous hematopoietic stem cell transplantation in chronic lymphocytic leukemia: results of European intergroup randomized trial comparing autografting versus observation	Michallet, M.; Dreger, P.; Sutton, L.; Brand, R.; Richards, S.; Os, M. van; Sobh, M.; Choquet, S.; Corront, B.; Dearden, C.; Gratwohl, A.; Herr, W.; Catovsky, D.; Hallek, M.; Witte, T.J. de.; Niederwieser, D.; Leporrier, M.; Milligan, D.
2011	Allogeneic stem cell transplantation for myelodysplastic syndromes with bone marrow fibrosis	Kroger, N.; Zabelina, T.; Biezen, A. van; Brand, R.; Niederwieser, D.; Martino, R.; Lim, Z.Y.; Onida, F.; Schmid, C.; Garderet, L.; Robin, M.; Gelder, M. van; Marks, R.; Symeonidis, A.; Kobbe, G.; Witte, T.J.M. de
2011	Tandem autologous/reduced-intensity conditioning allogeneic stem-cell transplantation versus autologous transplantation in myeloma: long-term follow-up	Bjorkstrand, B.; Iacobelli, S.; Hegenbart, U.; Gruber, A.; Greinix, H.; Volin, L.; Narni, F.; Musto, P.; Beksac, M.; Bosi, A.; Milone, G.; Corradini, P.; Goldschmidt, H.; Witte, T.J.M. de; Morris, C.; Niederwieser, D.; Gahrton, G.
2011	T cells expressing the activating NK-cell receptors KIR2DS4, NKG2C and NKG2D are elevated in paroxysmal nocturnal hemoglobinuria and cytotoxic toward hematopoietic progenitor cell lines	Bijnen, S.T.A. van; Withaar, H.M.; Preijers, F.W.M.B.; Meer, A. van der; Witte, Theo de; Muus, P.; Dolstra, H.
2011	Introduction of a quality management system and outcome after hematopoietic stem-cell transplantation	Gratwohl, A.; Brand, R.; Niederwieser, D.; Baldomero, H.; Chabannon, C.; Cornelissen, J.; Witte, T.J.M. de; Ljungman, P.; McDonald, F.; McGrath, E.; Passweg, J.; Peters, C.; Rocha, V.; Slaper-Cortenbach, I.; Sureda, A.; Tichelli, A.; Apperley, J.
2011	A polymorphism in the splice donor site of ZNF419 results in the novel renal cell carcinoma-associated minor histocompatibility antigen ZAPHIR	Broen, K.C.J.; Levenga, H.; Vos, J.C.M.; Bergen, K. van; Fredrix, H.; Greupink-Draaisma, A.L.; Kester, M.; Falkenburg, J.H.F.; Mulder, P.H.M. de; Witte, T.J.M. de; Griffioen, M.; Dolstra, H.
2011	Low-dose decitabine versus best supportive care in elderly patients with intermediate- or high-risk myelodysplastic syndrome (MDS) ineligible for intensive chemotherapy: final results of the randomized phase III study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study Group	Lubbert, M.; Suciu, S.; Baila, L.; Ruter, B.H.; Platzbecker, U.; Giagounidis, A.; Selleslag, D.; Labar, B.; Germing, U.; Salih, H.R.; Beeldens, F.; Muus, P.; Pfluger, K.H.; Coens, C.; Hagemeijer, A.; Eckart Schaefer, H.; Ganser, A.; Aul, C.; Witte, T.J.M. de; Wijermans, P.W.
2011	The PTPN22 R263Q polymorphism is a risk factor for rheumatoid arthritis in Caucasian case-control samples	Rodriguez-Rodriguez, L.; Taib, W.R.; Topless, R.; Steer, S.; Gonzalez-Escribano, M.F.; Balsa, A.; Pascual-Salcedo, D.; Gonzalez-Gay, M.A.; Raya, E.; Fernandez-Gutierrez, B.; Gonzalez-Alvaro, I.; Bottini, N.; Witte, T.J.M. de; Viken, M.K.; Coenen, M.J.H.; Riel, P.L. van; Franke, B.; Heijer, M. den; Radstake, T.R.D.J.; Wordsworth, P.; Lie, B.A.; Merriman, T.R.; Martin, J.
2011	Confirmation of association of the macrophage migration inhibitory factor gene with systemic sclerosis in a large European population	Bossini-Castillo, L.; Simeon, C.P.; Beretta, L.; Vonk, M.C.; Callejas-Rubio, J.L.; Espinosa, G.; Carreira, P.; Camps, M.T.; Rodriguez-Rodriguez, L.; Rodriguez-Carballeira, M.; Garcia-Hernandez, F.J.; Lopez-Longo, F.J.; Hernandez-Hernandez, V.; Saez-Comet, L.; Egurbide, M.V.; Hesselstrand, R.; Nordin, A.; Hoffmann-Vold, A.M.; Vanthuyne, M.; Smith, V.; Langhe, E. De; Kreuter, A.; Riemekasten, G.; Witte, T.J.M. de; Hunzelmann, N.; Voskuyl, A.E.; Schuerwegh, A.J.; Lunardi, C.; Airo, P.; Scorza, R.; Shiels, P.; Laar, J.M. van; Fonseca, C.; Denton, C.; Herrick, A.; Worthington, J.; Koeleman, B.P.; Rueda, B.; Radstake, T.R.D.J.; Martin, J.
2011	Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis	Diaz-Gallo, L.M.; Gourh, P.; Broen, J.; Simeon, C.; Fonollosa, V.; Ortego-Centeno, N.; Agarwal, S.; Vonk, M.C.; Coenen, M.J.H.; Riemekasten, G.; Hunzelmann, N.; Hesselstrand, R.; Tan, F.K.; Reveille, J.D.; Assassi, S.; Garcia-Hernandez, F.J.; Carreira, P.; Camps, M.T.; Fernandez-Nebro, A.; Pena, P.G. de la; Nearney, T.; Hilda, D.; Gonzalez-Gay, M.A.; Airo, P.; Beretta, L.; Scorza, R.; Herrick, A.; Worthington, J.; Pros, A.; Gomez-Gracia, I.; Trapiella, L.; Espinosa, G.; Castellvi, I.; Witte, T.J.M. de; Keyser, F. de; Vanthuyne, M.; Mayes, M.D.; Radstake, T.R.D.J.; Arnett, F.C.; Martin, J.; Rueda, B.
2011	Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy	Gorlova, O.; Martin, J.E.; Rueda, B.; Koeleman, B.P.; Ying, J.; Teruel, M.; Diaz-Gallo, L.M.; Broen, J.C.; Vonk, M.C.; Simeon, C.P.; Alizadeh, B.Z.; Coenen, M.J.H.; Voskuyl, A.E.; Schuerwegh, A.J.; Riel, P.L. van; Vanthuyne, M.; Slot, R. van 't; Italiaander, A.; Ophoff, R.A.; Hunzelmann, N.; Fonollosa, V.; Ortego-Centeno, N.; Gonzalez-Gay, M.A.; Garcia-Hernandez, F.J.; Gonzalez-Escribano, M.F.; Airo, P.; Laar, J. van; Worthington, J.; Hesselstrand, R.; Smith, V.; Keyser, F. de; Houssiau, F.; Chee, M.M.; Madhok, R.; Shiels, P.G.; Westhovens, R.; Kreuter, A.; Baere, E. de; Witte, T.J.M. de; Padyukov, L.; Nordin, A.; Scorza, R.; Lunardi, C.; Lie, B.A.; Hoffmann-Vold, A.M.; Palm, O.; Garcia de la Pena, P.; Carreira, P.; Varga, J.; Hinchcliff, M.; Lee, A.T.; Gourh, P.; Amos, C.I.; Wigley, F.M.; Hummers, L.K.; Hummers, J.; Nelson, J.L.; Riemekasten, G.; Herrick, A.; Beretta, L.; Fonseca, C.; Denton, C.P.; Gregersen, P.K.; Agarwal, S.; Assassi, S.; Tan, F.K.; Arnett, F.C.; Radstake, T.R.D.J.; Mayes, M.D.; Martin, J.
2011	A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort	Bossini-Castillo, L.; Broen, J.C.; Simeon, C.P.; Beretta, L.; Vonk, M.C.; Ortego-Centeno, N.; Espinosa, G.; Carreira, P.; Camps, M.T.; Navarrete, N.; Gonzalez-Escribano, M.F.; Vicente-Rabaneda, E.; Rodriguez, L.; Tolosa, C.; Roman-Ivorra, J.A.; Gomez-Gracia, I.; Garcia-Hernandez, F.J.; Castellvi, I.; Gallego, M.; Fernandez-Nebro, A.; Garcia-Portales, R.; Egurbide, M.V.; Fonollosa, V.; Pena, P.G. de la; Pros, A.; Gonzalez-Gay, M.A.; Hesselstrand, R.; Riemekasten, G.; Witte, T.J.M. de; Coenen, M.J.H.; Koeleman, B.P.; Houssiau, F.; Smith, V.; Keyser, F. de; Westhovens, R.; Langhe, E. De; Voskuyl, A.E.; Schuerwegh, A.J.; Chee, M.M.; Madhok, R.; Shiels, P.; Fonseca, C.; Denton, C.; Claes, K.; Padykov, L.; Nordin, A.; Palm, O.; Lie, B.A.; Airo, P.; Scorza, R.; Laar, J.M. van; Hunzelmann, N.; Kreuter, A.; Herrick, A.; Worthington, J.; Radstake, T.R.D.J.; Martin, J.; Rueda, B.
2010	The NDE1 gene is disrupted by the inv(16) in 90% of cases with CBFB-MYH11-positive acute myeloid leukemia.	Reijden, B.A. van der; Massop, M.; Simons, A.; Witte, T.J.M. de; Breuning, M.; Jansen, J.H.
2010	Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes.	Nikoloski, G.; Langemeijer, S.M.C.; Kuiper, R.P.; Knops, R.; Massop, M.; Tonnissen, E.R.; Heijden, A. van der; Scheele, T.N.; Berghe, P. van den; Witte, T.J.M. de; Reijden, B.A. van der; Jansen, J.H.
2010	Higher incidence of relapse in patients with acute myelocytic leukemia infused with higher doses of CD34+ cells from leukapheresis products autografted during the first remission.	Gorin, N.C.; Labopin, M.; Reiffers, J.; Milpied, N.; Blaise, D.; Witz, F.; Witte, T.J.M. de; Meloni, G.; Attal, M.; Bernal, T.; Rocha, V.
2010	Unrelated stem cell transplantation after reduced intensity conditioning for patients with multiple myeloma relapsing after autologous transplantation.	Kroger, N.; Shimoni, A.; Schilling, G.; Schwerdtfeger, R.; Bornhauser, M.; Nagler, A.; Zander, A.R.; Heinzelmann, M.; Brand, R.; Gahrton, G.; Morris, C.; Niederwieser, D.; Witte, T.J.M. de
2010	Solid organ transplantation after allogeneic hematopoietic stem cell transplantation: a retrospective, multicenter study of the EBMT.	Koenecke, C.; Hertenstein, B.; Schetelig, J.; Biezen, A. van; Dammann, E.; Gratwohl, A.; Ganser, A.; Schleuning, M.; Bornhauser, M.; Jacobsen, N.; Kroger, N.; Niederwieser, D.; Witte, T.J.M. de; Ruutu, T.
2010	Thalidomide and lenalidomide in primary myelofibrosis.	Holle, N.; Witte, T.J.M. de; Mandigers, C.M.P.W.; Schaap, N.P.M.; Raymakers, R.A.P.
2010	Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009.	Ljungman, P.; Bregni, M.; Brune, M.; Cornelissen, J.; Witte, T.J.M. de; Dini, G.; Einsele, H.; Gaspar, H.B.; Gratwohl, A.; Passweg, J.; Peters, C.; Rocha, V.; Saccardi, R.; Schouten, H.; Sureda, A.; Tichelli, A.; Velardi, A.; Niederwieser, D.
2010	Efficacy and outcome of autologous transplantation in rare myelomas.	Morris, C.; Drake, M.; Apperley, J.; Iacobelli, S.; Biezen, A. van; Bjorkstrand, B.; Goldschmidt, H.; Harousseau, J.L.; Morgan, G.; Witte, T.J.M. de; Niederwieser, D.; Gahrton, G.
2010	IJzergebreksanemie door een matriptase 2-mutatie	Cuijpers, M.L.H.; Wiegerinck, E.T.G.; Brouwer, R.; Witte, T.J.M. de; Swinkels, D.W.
2010	An alternatively spliced CXCL16 isoform expressed by dendritic cells is a secreted chemoattractant for CXCR6+ cells.	Voort, R. van der; Verweij, V.G.M.; Witte, T.J.M. de; Lasonder, E.; Adema, G.J.; Dolstra, H.
2010	Recent advances in the understanding of iron overload in sideroblastic myelodysplastic syndrome.	Cuijpers, M.L.H.; Raymakers, R.A.P.; Mackenzie, M.W.; Witte, T.J.M. de; Swinkels, D.W.
2010	siRNA silencing of PD-L1 and PD-L2 on dendritic cells augments expansion and function of minor histocompatibility antigen-specific CD8+ T cells.	Hobo, W.A.; Maas, F.M.H.M.; Adisty, N.; Witte, T.J.M. de; Schaap, N.P.M.; Voort, R. van der; Dolstra, H.
2010	High log-scale expansion of functional human natural killer cells from umbilical cord blood CD34-positive cells for adoptive cancer immunotherapy.	Spanholtz, J.; Tordoir, M.; Eissens, D.N.; Preijers, F.W.M.B.; Meer, A. van der; Joosten, I.; Schaap, N.P.M.; Witte, T.J.M. de; Dolstra, H.

1 2 3 4 next